Neonatal Platelet Transfusion Threshold Trial
NICHD Neonatal Research Network · with National Heart, Lung, and Blood Institute (NHLBI) · NCT06676904
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 2433
- US sites recruiting
- 20
- Study start
- June 13, 2025
- Record last updated
- March 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
Being studied: Higher Platelet Transfusion Threshold; Lower Platelet Transfusion Threshold
Conditions: Thrombocytopenia; Neonatal; Platelet Transfusion; Infant, Newborn, Diseases; Infant, Extremely Low Birth Weight; Infant, Small for Gestational Age; Thrombosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Gestational age of 23 0/7 to 26 6/7 weeks
- Postnatal age of \< 48 hours
Exclusion Criteria
- Comfort care or withdrawal of care planned
- Neonatal alloimmune thrombocytopenia or suspected/confirmed congenital platelet or bleeding disorder
- Receipt of platelet transfusion
- No receipt of Vitamin K
- Parents/guardian decline consent
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35233
Site contact: Waldemar A Carlo, MD
Stanford University
Palo Alto, CA 94304
Site contact: Valerie Chock, MD
Sharp Mary Birch Hospital for Women & Newborns
San Diego, CA 92123
Site contact: Anup Katheria, MD
University of Colorado
Aurora, CO 80045
Site contact: Sunah Hwang, MD
Emory University
Atlanta, GA 30303
Site contact: Ravi Patel, MD
Northwestern Lurie Children's Hospital of Chicago
Chicago, IL 60611
Site contact: Aaron Hamvas, MD
University of Iowa
Iowa City, IA 52242
Site contact: Tarah Colaizy, MD, MPH · 319-356-3508
Beth Israel Deaconess Medical Center
Boston, MA 02215
Site contact: Helen Healy, MD
University of New Mexico
Albuquerque, NM 87131
Site contact: Janell Fuller, MD
University of Rochester
Rochester, NY 14642
Site contact: Carl T D'Angio, MD
Duke University
Durham, NC 27710
Site contact: Michael Cotten, MD
Cincinnati Children's Medical Center
Cincinnati, OH 45267
Site contact: Stephanie Merhar, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, OH 44106
Site contact: Anna Maria Hibbs, MD
Nationwide Children's Hospital
Columbus, OH 43205
Site contact: Pablo Sanchez, MD
University of Pennsylvania
Philadelphia, PA 19104
Site contact: Sara DeMauro, MD
Vanderbilt University
Nashville, TN 37232
Site contact: Hendrick Weitkamp, MD
University of Texas Southwestern Medical Center at Dallas
Dallas, TX 75235
Site contact: Myra Myckoff, MD
University of Texas Health Science Center at Houston
Houston, TX 77030
Site contact: Jon Tyson
Pediatrix Medical Group
San Antonio, TX 78229
Site contact: Kaashif Ahmad, MD
University of Utah
Salt Lake City, UT 84108
Site contact: Robin Ohls, MD
Study contacts (from the official record)
- Ravi M Patel, MD · 404-727-5905 · rmpatel@emory.edu
- Abhik Das, PhD · 301-230-4640 · adas@rti.org
Similar studies in Alabama
All pregnancy studies in Alabama →- RecruitingHealthy volunteersPhase 1
Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
University of Alabama at Birmingham
- Location
- Birmingham, AL
- Eligibility basics
- Ages 14–89 · Women only
- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Birmingham, AL + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Birmingham, AL + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen Inc
- Location
- Huntsville, AL
- Eligibility basics
- Ages 1 mo–89